Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
The DOI matches its Crossref record.
Abstract
Lantibiotics are gene-encoded peptides that contain intramolecular ring structures, introduced through the thioether containing lanthionine and methyllanthionine residues. The overwhelming majority of the lantibiotics shows antibacterial activity. Some lantibiotics, e.g. nisin, are characterized by a dual mode of action. These peptides form a complex with the ultimate cell wall precursor lipid II, thereby inhibiting cell wall biosynthesis. The complexes then aggregate, incorporate further peptides and form a pore in the bacterial membrane. Recent results show that complexing of lipid II is widespread among lantibiotics; however, pore formation depends on the overall length of the peptide and the lipid composition of the test strain membrane. In the two-component system of lacticin 3147, the two functions are performed by the two different peptides. The genetic information for production of lantibiotics is organized in gene clusters which contain a structural gene (lanA) for the lantibiotic prepeptide. The modifications are introduced by one biosynthetic enzyme (LanM) or a combination of a dehydratase (LanB) and a cyclase (LanC). These enzymes have been in the focus of recent bioengineering studies: The structure of NisC has been resolved, the reaction mechanism of LctM was elucidated and the active site residues were characterized by mutagenesis studies. In vitro modification systems have successfully been used to introduce thioether rings into other biologically active peptides. Furthermore, variant lantibiotics with enhanced properties have been engineered and at least one promising new lantibiotic with strong activity against multiresistant pathogens has been described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
Self-citationBacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Probiotic Mechanisms of Action
Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C., & Gil, A. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,234
Diversity and applications of Bacillus bacteriocins
Abriouel, H., Franz, C. M. A. P., Omar, N. B., & Gálvez, A. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00244.x · Cited by 629
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
Cheng, G., Hao, H., Xie, S., Wang, X., Dai, M., Huang, L., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00217 · Cited by 622
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes
Repka, L. M., Chekan, J. R., Nair, S. K., & van der Donk, W. A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00591 · Cited by 547
Simons, A., Alhanout, K., & Duval, R. E. (2020) · Microorganisms · doi:10.3390/microorganisms8050639 · Cited by 547
Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments — A review
Cheng, W. N., & Han, S. G. (2020) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.20.0156 · Cited by 534
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
α‐Defensins in human innate immunity
Lehrer, R. I., & Lu, W. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01082.x · Cited by 429
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05338.x · Cited by 402
“Up to 11 subclasses have been suggested for lantibiotics (Cotter et al. 2005a; Bierbaum and Sahl 2009).”
BackgroundThe microbiome-shaping roles of bacteriocins
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H., & Peschel, A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00569-w · Cited by 395
The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota
Krismer, B., Weidenmaier, C., Zipperer, A., & Peschel, A. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.104 · Cited by 375
Bacterial strategies of resistance to antimicrobial peptides
Joo, H.-S., Fu, C.-I., & Otto, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0292 · Cited by 360
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
van Zyl, W. F., Deane, S. M., & Dicks, L. M. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1831339 · Cited by 340
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
“Recently, it was shown that nisin can produce short-lived pores that cause the cytoplasmic membrane to be permeable [51,60].”
BackgroundDiscovery, Biosynthesis, and Engineering of Lantipeptides
Knerr, P. J., & van der Donk, W. A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060110-113521 · Cited by 314
Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation
Ahmad, V., Khan, M. S., Jamal, Q. M. S., Alzohairy, M. A., Al Karaawi, M. A., & Siddiqui, M. U. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.016 · Cited by 293
Gut microbiota as a source of novel antimicrobials
Garcia-Gutierrez, E., Mayer, M. J., Cotter, P. D., & Narbad, A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1455790 · Cited by 292
Staphylococcus colonization of the skin and antimicrobial peptides
Otto, M. (2010) · Expert Review of Dermatology · doi:10.1586/edm.10.6 · Cited by 262
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
Schneider, T., & Sahl, H.-G. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.005 · Cited by 261
Self-citationAshaolu, T. J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110625 · Cited by 254
Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges
Biswaro, L. S., da Costa Sousa, M. G., Rezende, T. M. B., Dias, S. C., & Franco, O. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00855 · Cited by 227
“Further cysteine residues and unsaturated amino acids lead to the formation of lanthionine and B methyllanthionine residues, which in turn form rings in mature bacteriocin due to intermolecular cross linking (Bierbaum and Sahl, 2009).”
BackgroundEvolution of lanthipeptide synthetases
Zhang, Q., Yu, Y., Vélasquez, J. E., & van der Donk, W. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210393109 · Cited by 197
“S8) (8, 32) are grouped into a subclade with strong support (Fig.”
BackgroundUnveiling The Therapeutic Potential of Probiotics: A Review
Tukaram, K. S., Sopanrao, S. R., & Kacharu, L. O. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.09.011 · Cited by 19
Metadata
- Authors
- Bierbaum, G., & Sahl, H.-G.
- Venue
- Current Pharmaceutical Biotechnology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 10
- Issue
- 1
- Pages
- 2-18
- ISSN
- 1389-2010 (ISSN-L)
- OpenAlex
- W1986299243
- Cited by
- 524
- References
- 0
- FWCI
- 28.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.